{"status":"OK","data":{"advertisement":{"id":233642,"title":"Zapytanie ofertowe 25 10 2023 A","partial_offer_allowed":true,"publication_date":"2023-10-25","submission_deadline":"2023-11-02 23:59:59","planned_sign_date":"2023-11-01","supplementary_orders":"Zgodnie z tre\u015bci\u0105 zapytania ofertowego.","terms_of_contract_change":"Zgodnie z tre\u015bci\u0105 zapytania ofertowego.","created_at":"2023-10-25 15:28:25","modified_at":"2023-11-03 00:00:03","contact_persons":[{"id":58,"forename":"Anna","surname":"Dziedzicka","phone_number":"+48 538 512 756","email":"vendors.clinical@ryvu.com","created_by":null,"created_at":"2025-07-31 13:43:16","modified_at":"2025-07-31 13:43:16","modified_by":null}],"orders":[{"id":380651,"estimated_value":null,"order_items":[{"id":429729,"description":"AMES test\n\nMini AMES test - miniaturized test version.\nFluctuation test using Salmonella typhimurium with and without metabolic activation using liver S9 fraction.\nMaterial result in a form of the report or raw data results.\n\nMinimum number of samples to test/number of experiments to perform during the term of the contract is 1. \nMaximum number of samples to test/number of experiments to perform during the term of the contract is 4. \n","warranty_period":null,"cpv_items":[{"id":8514,"code":"73110000-6","name":"Us\u0142ugi badawcze"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":null,"created_at":"2023-10-25 15:28:25","modified_at":"2023-10-25 15:28:25","modified_by":null,"id":482186,"type":{"id":1,"name":"adres"},"group_uuid":"052ade06-fbb1-4e06-80e3-55224a431a6b"}],"participation_conditions":[],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":4,"name":"Us\u0142ugi badawcze"},"created_by":null,"created_at":"2023-10-25 15:28:25","modified_at":"2023-10-25 15:28:25","modified_by":null,"group_uuid":"40382427-ddd5-4e79-98a2-d9d86620a458"}],"evaluation_criteria":[{"id":654419,"price_criterion":true,"description":"Cena 100% (total net price)","created_by":null,"created_at":"2023-10-25 15:28:25","modified_at":"2023-10-25 15:28:25","modified_by":null,"group_uuid":"c2eb8a08-030a-44b8-b276-2672c3784f50"}],"is_variant":false,"title":"AMES test (part 1)","order_node":{"id":289124},"created_by":null,"created_at":"2023-10-25 15:28:25","modified_at":"2023-10-25 15:28:25","modified_by":null},{"id":380652,"estimated_value":null,"order_items":[{"id":429730,"description":"Safety panel\n\nAnalysis of: \nReceptors: Adenosine A2A, Adrenergic alpha 1A, Adrenergic alpha 2A, Adrenergic beta 1, Adrenergic beta 2, Cannabinoid CB1, Cannabinoid CB2, Cholecystokinin CCK1 (CCKa), Dopamine D1, Dopamine D2S, Endothelin Eta, Histamine H1, Histamine H2, Muscarinic M1, Muscarinic M2, Muscarinic M3, Opioid and opioid like: delta2 (DOP), Opioid and opioid like: kappa (KOP), Opioid and opioid like: mu (MOP), Serotonin 5-HT1A, Serotonin 5-HT1B, Serotonin 5-HT2A, Serotonin 5-HT2B, Vasopresin V1a.\nTransporters: Dopamine, norepinephrine, serotonin.\nIon channels: GABA (BZD), Glutamate (NMDA), Nicotinic Nneuronal a4b2, Serotonin 5-HT3, Ca2+ L channel, K+ - hERG, Kv, Na+.\nNuclear receptors: Steroid nuclear receptors: AR, Steroid nuclear receptors: GR.\nKinases: CTK: Lck kinase.\nOther: AA metabolism: COX1, AA metabolism: COX2, Neuroamine and neurotransmiter: acetylocholinesterase, Neuroamine and neurotransmiter: MAO-A, Phosphodiesterases: PDE3A, Phosphodiesterases: PDE4D2.\nMaterial result in a form of the report or raw data results.\n\nMinimum number of samples to test/number of experiments to perform during the term of the contract is 1. \nMaximum number of samples to test/number of experiments to perform during the term of the contract is 4. ","warranty_period":null,"cpv_items":[{"id":8514,"code":"73110000-6","name":"Us\u0142ugi badawcze"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":null,"created_at":"2023-10-25 15:28:25","modified_at":"2023-10-25 15:28:25","modified_by":null,"id":482187,"type":{"id":1,"name":"adres"},"group_uuid":"c9944c18-8a66-4a0f-9fcf-7ca118176aef"}],"participation_conditions":[],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":4,"name":"Us\u0142ugi badawcze"},"created_by":null,"created_at":"2023-10-25 15:28:25","modified_at":"2023-10-25 15:28:25","modified_by":null,"group_uuid":"3cb7ef8d-4311-4f7f-ba63-c869e2fc4706"}],"evaluation_criteria":[{"id":654420,"price_criterion":true,"description":"Cena 100% (total net price)","created_by":null,"created_at":"2023-10-25 15:28:25","modified_at":"2023-10-25 15:28:25","modified_by":null,"group_uuid":"9998b418-b1d3-43c6-a87c-c8853941fe21"}],"is_variant":false,"title":"Safety panel (part 2)","order_node":{"id":289125},"created_by":null,"created_at":"2023-10-25 15:28:25","modified_at":"2023-10-25 15:28:25","modified_by":null},{"id":380653,"estimated_value":null,"order_items":[{"id":429731,"description":"Micronucleus Panel\n\nIn Vitro DNA Damage in Mammalian Cells (Example: In Vitro Chromosome Aberration Assay, Mouse Lymphoma Assay, In Vitro Micronucleus Assay)\nThe chromosomal aberration test is designed to identify agents that cause structural chromosomal aberrations by using cultured mammalian somatic cells (peripheral blood lymphocytes, Chinese Hamster Ovary cell line (CHO)). \nMaterial result in a form of the report or raw data results.\n\nMinimum number of samples to test/number of experiments to perform during the term of the contract is 1. \nMaximum number of samples to test/number of experiments to perform during the term of the contract is 4. \n","warranty_period":null,"cpv_items":[{"id":8514,"code":"73110000-6","name":"Us\u0142ugi badawcze"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":null,"created_at":"2023-10-25 15:28:25","modified_at":"2023-10-25 15:28:25","modified_by":null,"id":482188,"type":{"id":1,"name":"adres"},"group_uuid":"574fa726-b34e-4802-a9ce-288291923be1"}],"participation_conditions":[],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":4,"name":"Us\u0142ugi badawcze"},"created_by":null,"created_at":"2023-10-25 15:28:25","modified_at":"2023-10-25 15:28:25","modified_by":null,"group_uuid":"d3129529-1ff3-4923-babd-485e5f150c7e"}],"evaluation_criteria":[{"id":654421,"price_criterion":true,"description":"Cena 100% (total net price)","created_by":null,"created_at":"2023-10-25 15:28:25","modified_at":"2023-10-25 15:28:25","modified_by":null,"group_uuid":"830e210a-659c-429e-af02-5d50008d22e8"}],"is_variant":false,"title":"Micronucleus Panel (part 3)","order_node":{"id":289126},"created_by":null,"created_at":"2023-10-25 15:28:25","modified_at":"2023-10-25 15:28:25","modified_by":null},{"id":380654,"estimated_value":null,"order_items":[{"id":429732,"description":"Kinase assay panel\n\nKinase selectivity panel based on active site-directed competition binding assay. Performed at one concentration in duplicate. Panel should contain >450 kinases. Screening \"hits\" should be  identified by measuring the amount of kinase captured in test versus control samples by using a quantitative qPCR method that detects the associated DNA label.\nMaterial result in a form of the report or raw data results.\n\nMinimum number of samples to test/number of experiments to perform during the term of the contract is 1. \nMaximum number of samples to test/number of experiments to perform during the term of the contract is 4. \n","warranty_period":null,"cpv_items":[{"id":8514,"code":"73110000-6","name":"Us\u0142ugi badawcze"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":null,"created_at":"2023-10-25 15:28:25","modified_at":"2023-10-25 15:28:25","modified_by":null,"id":482189,"type":{"id":1,"name":"adres"},"group_uuid":"05b33857-3a02-4d5e-9212-0e48b38413ac"}],"participation_conditions":[{"id":1173835,"description":"Wymagania zamieszczono w za\u0142\u0105czonym Zapytaniu Ofertowym.","type":{"id":7,"name":"Dodatkowe warunki udzia\u0142u"},"created_by":null,"created_at":"2023-10-25 15:28:25","modified_at":"2023-10-25 15:28:25","modified_by":null,"group_uuid":"ce52090d-b630-4835-ba9d-02678b52ca67"},{"id":1173836,"description":"Uzupe\u0142niony Za\u0142\u0105cznik 1 (Appendix 1).","type":{"id":6,"name":"Lista wymaganych dokument\u00f3w/o\u015bwiadcze\u0144"},"created_by":null,"created_at":"2023-10-25 15:28:25","modified_at":"2023-10-25 15:28:25","modified_by":null,"group_uuid":"8730367a-790b-48c8-901f-38ebc9cf8c11"}],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":4,"name":"Us\u0142ugi badawcze"},"created_by":null,"created_at":"2023-10-25 15:28:25","modified_at":"2023-10-25 15:28:25","modified_by":null,"group_uuid":"e8d6e474-bc4e-4fd9-a7bd-231024c5206e"}],"evaluation_criteria":[{"id":654422,"price_criterion":true,"description":"Cena 100% (total net price)","created_by":null,"created_at":"2023-10-25 15:28:25","modified_at":"2023-10-25 15:28:25","modified_by":null,"group_uuid":"e55de6aa-8ba5-45f6-a571-40e3fa53b527"}],"is_variant":false,"title":"Kinase assay panel (part 4)","order_node":{"id":289127},"created_by":null,"created_at":"2023-10-25 15:28:25","modified_at":"2023-10-25 15:28:25","modified_by":null}],"created_by":{"id":112,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"RYVU THERAPEUTICS S.A.","identification_number_type":"nip","identification_number":"6792942955","address":{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":null,"created_at":null,"modified_at":null,"modified_by":null,"id":615649,"street":"Leona Sternbacha","number_description":"2","postcode":"30-394"},"created_by":{"id":112,"contact_persons":[]},"created_at":"2023-10-25 15:28:25","modified_at":"2023-10-25 15:28:25","modified_by":{"id":112,"contact_persons":[]},"id":234178},"advertisement":{"id":177944,"number":"2023-112-177944","publication_date":"2023-10-25","created_by":{"id":112,"contact_persons":[]},"created_at":"2023-10-25 15:28:25","modified_at":"2023-11-03 00:00:03","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[233642],"enrollment":{"id":39917,"name":"Rozw\u00f3j celowanej terapii przeciwnowotworowej opartej o zahamowanie helikazy WRN (CanSL)","number":"002/23","activity":{"created_by":null,"created_at":"2023-02-01 09:22:25","modified_at":"2023-02-01 09:22:25","modified_by":null},"region":null,"institution":{"created_by":null,"created_at":"2023-02-01 09:28:01","modified_at":"2023-02-01 09:28:01","modified_by":null},"full_number":"FENG.01.01-IP.02-002/23","perspective":{},"programme":{"created_by":null,"created_at":"2023-02-01 09:21:41","modified_at":"2023-02-01 09:21:41","modified_by":null},"priority":{"created_by":null,"created_at":"2023-02-01 09:21:51","modified_at":"2023-02-01 09:21:51","modified_by":null},"type":"enrollment","created_by":null,"created_at":"2023-07-17 12:04:06","modified_at":"2023-07-17 12:04:06","modified_by":null},"projects":[],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":233642,"publication_date":"2023-10-25"},"id":1171992,"name":"RFQ 25 10 2023 A (Zapytanie ofertowe 25 10 2023 A)","file":{"id":1305949,"name":"RFQ 25 10 2023 A.pdf","created_at":"2023-10-25 15:22:16","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/1305949"},"group_uuid":"710982c5-c47d-4b8f-9dd1-a03cd7dab21b"},{"origin":{"id":233642,"publication_date":"2023-10-25"},"id":1171993,"name":"Offer form to 25 10 2023 A/Appendix 1 (Formularz/Za\u0142\u0105cznik 1 do zapytania ofertowego 25 10 2023 A)","file":{"id":1305957,"name":"Offer form to 25 10 2023 A - Appendix 1.docx","created_at":"2023-10-25 15:26:20","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/1305957"},"group_uuid":"6c81d8ea-62a3-4eb5-bf94-80f1ab055c19"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}